NCT06799780

Brief Summary

The main objective of the study is to identify the optimal surgical timing for the treatment of intraventricular defects after acute myocardial infarction.

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
7mo left

Started Feb 2024

Typical duration for all trials

Geographic Reach
2 countries

4 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress80%
Feb 2024Nov 2026

Study Start

First participant enrolled

February 12, 2024

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

November 28, 2024

Completed
2 months until next milestone

First Posted

Study publicly available on registry

January 29, 2025

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2026

Last Updated

January 29, 2025

Status Verified

October 1, 2024

Enrollment Period

2.8 years

First QC Date

November 28, 2024

Last Update Submit

January 28, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Identify the optimal timing for the surgical intervention.

    The optimal timing considering the time interval between the clinical-instrumental diagnosis and the surgical intervention

    Possible timing for surgery can be: onset of the infarction episode, hospital admission, before seven days from the acute myocardial infarction or after seven days from the acute myocardial infarction.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients undergoing surgical repair of post-AMI ventricular septal defect between January 1, 2001 and December 31, 2021.

You may qualify if:

  • Patients over eighteen years of age
  • Patients with post-myocardial infarction ventricular septal defect treated surgically
  • Patients who have signed the informed consent

You may not qualify if:

  • Patients with post-infarction ventricular septal defect treated with medical/conservative therapy
  • Patients with ventricular septal defects not due to acute myocardial infarction

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Bologna, Bologna, 40138, Italy

RECRUITING

Ospedale Santa Maria della Misericordia Udine

Udine, Udine, 33100, Italy

RECRUITING

Ospedale di Circolo e Fondazione Macchi Varese

Varese, Varese, 21010, Italy

RECRUITING

Hospital Clinic Barcellona

Barcelona, Barcellona, 08024, Spain

RECRUITING

MeSH Terms

Conditions

Myocardial InfarctionHeart Diseases

Condition Hierarchy (Ancestors)

Myocardial IschemiaCardiovascular DiseasesVascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosis

Study Officials

  • Luca Di Marco, MD

    IRCCS Azienda Ospedaliero-Universitaria di Bologna

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Luca Di Marco, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 28, 2024

First Posted

January 29, 2025

Study Start

February 12, 2024

Primary Completion (Estimated)

November 30, 2026

Study Completion (Estimated)

November 30, 2026

Last Updated

January 29, 2025

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Locations